David Lowrance
2019
In 2019, David Lowrance earned a total compensation of $699K as Chief Financial Officer & Secretary at Mast Therapeutics, a 68% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $116,727 |
|---|---|
| Option Awards | $180,706 |
| Salary | $379,600 |
| Other | $22,000 |
| Total | $699,033 |
Lowrance received $379.6K in salary, accounting for 54% of the total pay in 2019.
Lowrance also received $116.7K in non-equity incentive plan, $180.7K in option awards and $22K in other compensation.
Rankings
In 2019, David Lowrance's compensation ranked 10,693rd out of 13,971 executives tracked by ExecPay. In other words, Lowrance earned more than 23.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,693 out of 13,971 | 24th |
Division Manufacturing | 4,322 out of 5,695 | 24th |
Major group Chemicals And Allied Products | 1,676 out of 2,194 | 24th |
Industry group Drugs | 1,433 out of 1,880 | 24th |
Industry Pharmaceutical Preparations | 1,060 out of 1,392 | 24th |
Source: SEC filing on April 15, 2020.
Lowrance's colleagues
We found two more compensation records of executives who worked with David Lowrance at Mast Therapeutics in 2019.